Cholecalciferol(Vitamin D3)是维生素D的天然存在形式,代谢激活后能诱导细胞分化和癌细胞增殖。
Vitamin D3 is a form of vitamin D, binds and activates a H305F/H397Y mutant vitamin D receptor (VDR) with EC50 of 300 nM.
~ 100 nM
~10.0 mg/kg 口服
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Ousley AM, et al. J Steroid Biochem Mol Biol, 2011, 125(3-5), 202-210.
[2] Holick, M.F., Rec. Res. Canc. Res., 164, 3 (2003)
[3] Palmer, H.G., et al.: Cancer Res., 63, 7799 (2003)
[4] Welsh, J., et al.: J. Nutr., 133, 2425S (2003)
分子式 C27H44O |
分子量 384.64 |
CAS号 67-97-0 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 65 mg/mL |
Water <1 mg/mL |
Ethanol 65 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01877577 | Crohn's Disease (CD)|Ulcerative Colitis (UC) | Dietary Supplement: Vitamin D3 | University of California, San Francisco | 2012-04-01 | 2014-07-01 | |
NCT01650883 | Vitamin D 25 OH Deficiency | Dietary Supplement: Cholecalciferol|Dietary Supplement: Cholecalciferol 5,000 IU | University of South Florida | 2009-03-01 | 2012-07-25 | |
NCT00789880 | Atopic Dermatitis|Psoriasis | Drug: Vitamin D3|Drug: Placebo | National Institute of Allergy and Infectious Diseases (NIAID)|Consortium of Food Allergy Research | Phase 2 | 2008-12-01 | 2015-06-02 |
NCT01024777 | Multiple Sclerosis|Vitamin D Deficiency | Drug: Cholecalciferol|Drug: Cholecalciferol | Johns Hopkins University | Phase 1 | 2010-03-01 | 2013-02-05 |
NCT00956839 | Pancreatitis, Chronic | Drug: Vitamin D3 (Cholecalciferol) | Sanjay Gandhi Postgraduate Institute of Medical Sciences | Phase 4 | 2009-07-01 | 2013-02-10 |
NCT01045109 | Prostate Cancer | Dietary Supplement: cholecalciferol|Dietary Supplement: cholecalciferol | Medical University of South Carolina | Phase 2 | 2007-10-01 | 2011-08-04 |
NCT02735200 | Vitamin D Deficiency | Drug: topical vitamin D3 in intervention group | Dammam University | Phase 1|Phase 2 | 2016-04-01 | 2017-01-23 |
NCT00710021 | Systemic Lupus Erythematosus|SLE|Lupus | Drug: Vitamin D3|Drug: Vitamin D3 placebo | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence | Phase 2 | 2008-11-01 | 2015-11-07 |
NCT02999204 | Renal Insufficiency, Chronic|Vascular Stiffness|Bone Diseases, Metabolic | Drug: Vitamin D3 | Jewish General Hospital | Phase 4 | 2014-01-01 | 2016-12-16 |
NCT01709474 | Systemic Lupus Erythematosus | Drug: Vitamin D3 6000 IU|Drug: Vitamin D3 400 IU | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence | Phase 2 | 2013-06-01 | 2015-12-15 |
NCT00858247 | Obesity | Dietary Supplement: Vitamin D3 | Mayo Clinic|National Center for Research Resources (NCRR)|Thrasher Research Fund | Phase 2 | 2009-04-01 | 2014-05-13 |
NCT02535910 | Hypovitaminosis D|Cardiovascular Diseases | Dietary Supplement: vitamin D3|Dietary Supplement: 25(OH) D3|Dietary Supplement: Control | University of Reading | 2015-08-01 | 2015-09-23 | |
NCT02063334 | Vitamin D Receptor Target Gene Expression|Serum 25(OH)D Concentration | Dietary Supplement: Vitamin D3|Dietary Supplement: Placebo | University of Eastern Finland | Phase 1 | 2014-02-01 | 2016-07-28 |
NCT00656929 | Viral Upper Respiratory Tract Infection | Dietary Supplement: Vitamin D3|Other: Placebo | Winthrop University Hospital | 2006-12-01 | 2008-04-10 | |
NCT00752401 | Kidney Transplantation|Vitamin D Deficiency|Renal Osteodystrophy | Drug: Cholecalciferol|Drug: Placebo | Medical University of Vienna | Phase 3 | 2009-05-01 | 2014-01-20 |
NCT01508845 | Vitamin D Deficiency | Dietary Supplement: cholecalciferol|Dietary Supplement: cholecalciferol|Dietary Supplement: cholecalciferol|Dietary Supplement: cholecalciferol | Tufts University|Pfizer | 2012-01-01 | 2014-07-18 | |
NCT02359214 | Cardiovascular Disease|Diabetes|Bone Disease | Dietary Supplement: Vitamin D3|Other: Placebo | University of Chester | 2014-04-01 | 2016-10-25 | |
NCT01170507 | Vitamin D Deficiency | Drug: vitamin D3 1000 IU orally daily for 5 months|Drug: vitamin D3 3000 IU orally daily for 5 months|Drug: vitamin D3 5000 IU orally daily for 5 months|Drug: Placebo orally daily for 5 months | King Faisal Specialist Hospital & Research Center | Phase 1|Phase 2 | 2011-12-01 | 2016-08-29 |
NCT00940719 | Multiple Sclerosis | Dietary Supplement: vitamin D3 | Maastricht University Medical Center|Orbis Medical Centre | 2009-08-01 | 2010-08-10 | |
NCT01268176 | Vitamin D Deficiency | Dietary Supplement: cholecalciferol | Tufts University|Pfizer | Phase 1 | 2010-12-01 | 2013-05-09 |
NCT02407899 | Diabetes Mellitus, Type 1 | Drug: Saxagliptin|Drug: Vitamin D3|Drug: Insulin | Second Xiangya Hospital of Central South University|National Clinical Research Center for Metabolic Diseases, China | Phase 4 | 2015-03-01 | 2015-11-17 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们